Paper Details 
Original Abstract of the Article :
Drug abuse remains a serious public health issue, underscoring the need for additional treatment options. Agonists at serotonin (5-HT)2C receptors, particularly lorcaserin, are being considered as pharmacotherapies for abuse of a variety of drugs, including cocaine and opioids. The current study com...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/30382731

データ提供:米国国立医学図書館(NLM)

Lorcaserin: A Potential Weapon Against Drug Relapse?

The struggle with drug addiction is a complex and multifaceted challenge, demanding innovative solutions to prevent relapse. This research investigates the potential of lorcaserin, a serotonin (5-HT)2C receptor agonist, as a pharmacotherapy for drug abuse, focusing on its ability to attenuate reinstatement of drug-seeking behavior in rhesus monkeys. The authors conducted a study comparing the effects of lorcaserin on reinstatement of responding previously maintained by cocaine or remifentanil, a potent opioid analgesic. They explored the potential of lorcaserin to reduce relapse-related behaviors, a crucial aspect of drug abuse treatment.

Lorcaserin: A Potential Tool for Relapse Prevention

This study provides promising evidence for the potential of lorcaserin in reducing relapse-related behaviors in drug abusers. The authors found that lorcaserin dose-dependently attenuated reinstated responding, both for cocaine and heroin. This suggests that lorcaserin may have a broad-spectrum effect across different classes of abused drugs, making it a potential tool for managing polydrug abuse.

A New Approach to Relapse Prevention: Harnessing the Power of Serotonin

This research highlights the potential of targeting serotonin (5-HT)2C receptors as a therapeutic strategy for drug abuse. The authors found that lorcaserin, a 5-HT2C receptor agonist, effectively reduced drug-seeking behavior in a preclinical model of relapse. This research encourages further investigation into the use of 5-HT2C receptor agonists as pharmacotherapies for drug abuse, potentially offering a new avenue for relapse prevention and improving outcomes for individuals struggling with addiction.

Dr. Camel's Conclusion

This research is like a desert mirage, offering a glimpse of hope for individuals struggling with drug addiction. Lorcaserin may prove to be a valuable tool in the fight against relapse, potentially helping individuals break free from the cycle of addiction and reclaim their lives. This journey into the realm of addiction treatment reminds us that even the most challenging conditions can be addressed with innovative research and a commitment to finding effective solutions.

Date :
  1. Date Completed 2019-03-15
  2. Date Revised 2021-01-09
Further Info :

Pubmed ID

30382731

DOI: Digital Object Identifier

NIHMS988980

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.